Can clinical data predict progression to dementia in amnestic mild cognitive impairment?

Canadian Journal of Neurological Sciences

Volumn 35, Issue 3, 2008, Pages 314-322

  Fellows, Lesley ^a   Bergman, Howard ^a   Wolfson, Christina ^b   Chertkow, Howard ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE DE RECHERCHE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL STUDY; COGNITIVE DEFECT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPSYCHOLOGICAL TEST; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 51349092925     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008891     Document Type: Article

References (100)

1. Chertkow H. Mild cognitive impairment. Curr Opin Neurol. 2002; 15(4):401-7.
2. Chertkow H, Nasreddine Z, Joanette Y, Drolet V, Kirk J, Massoud F, et al. Mild cognitive impairment and cognitive impairment, no dementia: part A, concept and diagnosis. Alzheimers Dement. 2007;3(4):266-82.
3. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization; 1992.
4. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8.
5. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133-42.
6. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3): 240-6.
7. Berg L. Clinical dementia rating (CDR). Psychopharmacol Bull. 1988; 24(4):637-9.
8. Morris JC, McKeel DW, Jr., Storandt M, Rubin EH, Price JL, Grant EA, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology. 1991;41(4):469-78.
9. Petersen RC. Mild cognitive impairment or questionable dementia? Arch Neurol. 2000;57(5):643-4.
10. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58(3):397-405.
11. Levy R. Aging-associated cognitive decline. International Geriatrics. 1994;6(1):63-7.
12. Patterson C, Feightner J, Garcia A, MacKnight C. General risk factors for dementia: a systematic evidence review. Alzheimers Dement. 2007;3(4):341-7.
13. Alexopoulos P, Grimmer T, Perneczky R, Domes G, Kurz A. Do all patients with mild cognitive impairment progress to dementia? J Am Geriatr Soc. 2006;54(6):1008-10.
14. Eckman CB, Eckman EA. An update on the amyloid hypothesis. Neurol Clin. 2007;25(3):669-82.
15. Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc. 1997;45(3):321-8.
16. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41(7): 1006-9.
17. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-5.
18. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64(5):834-41.
19. Petersen RC, Smith, GE, Tangalos, EG, Kokmen, E, Ivnik, RJ. Longitudinal outcome of patients with a mild cognitive impairment. Ann Neurol. 1993;34:294-5.
20. Grundman M, Thal L. Clinical trials to prevent Alzheimer's disease in a population at-risk, in Alzheimer disease: In: Molecular Biology to Therapy, Becker R, Giacobini E, Editors. Boston: Birkhauser; 1996. p. 375-9.
21. Thal LJ. Potential prevention strategies for Alzheimer disease [see comments]. Alzheimer Dis Assoc Disord. 1996;10(Suppl 1):6-8.
22. Dawe B, Procter A. Concepts of mild memory impairment in the elderly and their relationship to dementia - a review. Int J Geriatr Psychiatry. 1992;7:473-9.
23. Ritchie K, Leibovici D, Ledesert B, Touchon J. A typology of sub-clinical senescent cognitive disorder. B J Psychiatry. 1996; 168(4):470-6.
24. Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology. 2006; 67(7):1201-7.
25. Chertkow H, Bergman H, LeBlanc A, McKelvey R, Chong G, Whitehead V. Amnestic Mild Cognitive Impairment, Natural history and progression to dementia in a memory clinic. Neurology. 2006;(submitted).
26. Chertkow H. Five year follow-up of Mild Cognitive Impairment - predictors of progression. The 8th International Conference on Alzheimer's Disease and Related Disorders. Stockholm; 2002.
27. Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, and Marson DC. Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc. 2006;12(2):166-75.
28. Visser PJ, Verhey F, Scheltens P, Cruts M, Ponds RW, Van Broeckhoven C, et al. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects. J Neurol. 2001;249:312-19.
29. Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2007.
30. Lauren L, Andersen K, Dewey M, Latenneur L, Ott A, Amaducci L, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. 1999;52: 78-84.
31. Mayeux R, Stern Y, and Spanton S. Heterogeneity in dementia of the Alzheimer's type: evidence of subgroups. Neurology. 1985;35(4):453-61.
32. Mortimer JA, French LR, Hutton JT, Schuman LM. Head injury as a risk factor for Alzheimer's disease. Neurology. 1985;35(2): 264-7.
33. Borenstein AR, Copenhaver CI, Mortimer JA. Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord. 2006; 20(1):63-72.
34. Jorm A, Duijn Cv, Chandra V, and al. e. Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20 Suppl 2:S43-7.
35. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003;60(5):753-9.
36. Mortimer JA, Graves AB. Education and other socioeconomic determinants of dementia and Alzheimer's disease. Neurology. 1993;43 Suppl 4:S39-S44.
37. Small GW, La Rue A, Komo S, Kaplan A, Mandelkern MA. Predictors of cognitive change in middle-aged and older adults with memory loss. Am J Psychiatry. 1995;152(12):1757-64.
38. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5(9):735-41.
39. Brayne C, Gill C, Huppert FA, Barkley C, Gehlhaar E, Girling DM, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for later life. Br J Psychiatry. 1995;167:255-62.
40. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1997;48:132-8.
41. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995; 45:1161-8.
42. Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993;43(3 Pt 1):515-9.
43. Andersen K, Nielsen H, Lolk A, Andersen J, Becker I, Kragh-Sørensen P. Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense. Neurology. 1999;52:85-90.
44. Paykel E, Brayne C, Huppert F, Gill C, Barkley C, Gehlhaar E, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry. 1994;51:325-32.
45. Barnes LL, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Gender, cognitive decline, and risk of AD in older persons. Neurology. 2003;60(11):1777-81.
46. Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology. 2006;66(6):828-32.
47. Schmand B, Jonker C, Hooijer C, Lindeboom J. Subjective memory complaints may announce dementia. Neurology. 1996;46(1):121-5.
48. Schofield PW, Jacobs D, Marder K, Sano M, Stern Y. The validity of new memory complaints in the elderly. Arch Neurol. 1997;54(6):756-9.
49. Jonker C, Launer LJ, Hooijer C, Lindeboom J. Memory complaints and memory impairment in older individuals. J Am Geriatr Soc. 1996;44(1):44-9.
50. Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA. Memory complaints are related to Alzheimer disease pathology in older persons. Neurology. 2006;67(9):1581-5.
51. McGlone J, Gupta S, Humphrey D, Oppenheimer S, Mirsen T, Evans DR. Screening for early dementia using memory complaints from patients and relatives. Arch Neurol. 1990;47(11):1189-93.
52. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005;65(4):559-64.
53. Galvin JE, Roe CM, Xiong C, Morris JC. Validity and reliability of the AD8 informant interview in dementia. Neurology. 2006;67(11):1942-8.
54. Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC. Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med. 2003;33(6):1029-38.
55. Hofman A, de Jong PT, van Duijn CM, Breteler MM. Epidemiology of neurological diseases in elderly people: what did we learn from the Rotterdam Study? Lancet Neurol. 2006;5(6):545-50.
56. De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52(3): 335-41.
57. den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry. 2006;63(1):57-62.
58. van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Atherosclerosis and risk for dementia. Ann Neurol. 2007;61(5):403-10.
59. van Dijk EJ, Breteler MM, Schmidt R, Berger K, Nilsson LG, Oudkerk M, et al. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension. 2004;44(5): 625-30.
60. Almeida OP, Hulse GK, Lawrence D, Flicker L. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction. 2002;97(1):15-28.
61. Chui HC, Lyness SA, Sobel E, Schneider LS. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol. 1994;51(7):676-81.
62. Huff FJ, Boller F, Lucchelli F, Querriera R, Beyer J, Belle S. The neurologic examination in patients with probable Alzheimer's disease. Arch Neurol. 1987;44:929-33.
63. Richards M, Folstein M, Albert M, Miller L, Bylsma F, Lafleche G, et al. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Dis Assoc Disord. 1993;7(1):22-32. [published erratum appears in Alzheimer Dis Assoc Disord 1993 Winter;7(4):239]
64. O'Keeffe ST, Kazeem H, Philpott RM, Playfer JR, Gosney M, Lye M. Gait disturbance in Alzheimer's disease: a clinical study. Age Ageing. 1996;25(4):313-6.
65. Ramakers IH, Visser PJ, Aalten P, Boesten JH, Metsemakers JF, Jolles J, et al. Symptoms of preclinical dementia in general practice up to five years before dementia fiagnosis. Dement Geriatr Cogn Disord. 2007;24(4):300-6.
66. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology. 1996;46(3):661-5.
67. Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol. 1989;46(4):379-82.
68. Galvin JE, Roe CM, Morris JC. Evaluation of cognitive impairment in older adults: combining brief informant and performance measures. Arch Neurol. 2007;64(5):718-24.
69. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet. 2006;367 (9518): 1262-70.
70. Petersen RC, R. VN, Ivnik RJ, Tangalos EG, Kokmen E. "Mild cognitive impairment: linical characterization and outcome". Correction. Arch Neurol. 1999;56(6).
71. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry. 2006;77(6):714-8.
72. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8. [published erratum appears in Arch Neurol 1999 Jun;56(6):760]
73. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273(16):1274-8. [published erratum appears in JAMA 1995 Aug 16;274(7):538]
74. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-94.
75. Darvesh S, Leach L, Black SE, Kaplan E, Freedman M. The behavioural neurology assessment. Can J Neurol Sci 2005; 32(2):167-77.
76. McKhann G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health Services Task Force on Alzheimer's diesase. Neurology. 1984;34:939-44.
77. Hughes C, Berg L, Danziger W, Coben L, Martin R. A new clinical scale for the staging of dementia. B J Psychiatry. 1982;140: 566-72.
78. Babins L, Slater ME, Whitehead V, and Chertkow HM. Can an 18-point clock drawing scoring system predict dementia in elderly individuals with mild cognitive impairment? J Clin Exp Neuropsychol. 2007:1-14.
79. Duong A, Whitehead V, Hanratty K, Chertkow H. The nature of lexico-semantic processing deficits in mild cognitive impairment. Neuropsychologia. 2006;44(10):1928-35.
80. Chertkow H. Mild Cognitive Impairment. The Canadian Azheimer's Disease Review. 2002:15-20.
81. Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58(5):758-64.
82. Hachinski VC, Iliff LD, Zilhka E, duBoulay GHD, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632-7.
83. Folstein MF, Folstein SE, and McHugh PR. "Mini-mental state" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-98.
84. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24(4):709-11.
85. Spreen O and Strauss E, eds. A compendium of neuropsychological tests: Administration norms and commentary. New York: Oxford University Press; 1998. p. 326-40.
86. Wechsler D. Wechsler Memory Scale - Revised. San Antonio: The Psychological Corporation; 1987.
87. Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Teri L, et al. Relationship between cigarette smoking and ALzheimer's disease in a population-based case-control study. Neurology. 1993;43(2):293-300.
88. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20 Suppl 2:S48-57.
89. Quirion R. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. J Psychiatry Neurosci. 1993;18(5):226-34.
90. Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology. 2005;64(7):1157-61.
91. Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA. The relation of cognitive activity to risk of developing Alzheimer's disease. Neurology. 2007;69(20):1911-20.
92. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58(3):498-504.
93. Verghese J, Levalley A, Derby C, Kuslansky G, Katz M, Hall C, et al. Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology. 2006; 66:821-7.
94. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3(6):343-53.
95. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC, et al. Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology. 2002;59(12): 1915-21.
96. Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA. Incident dementia in women is preceded by weight loss by at least a decade. Neurology. 2007;69(8):739-46.
97. Wilson RS, Arnold SE, Schneider JA, Li Y, Bennett DA. Chronic distress, age-related neuropathology, and late-life dementia. Psychosom Med. 2007;69(1):47-53.
98. Wilson RS, Krueger KR, Arnold SE, Schneider JA, Kelly JF, Barnes LL, et al. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry. 2007;64(2):234-40.
99. Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA. Chronic distress and incidence of mild cognitive impairment. Neurology. 2007;68(24):2085-92.
100. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332(7539):455-9.